Modulation of brain insulin signaling in Alzheimer’s disease: New insight on the protective role of green coffee bean extract

References

• Zhang DM, Jiao RQ, Kong LD. High dietary fructose: direct or indirect dangerous factors disturbing tissue and organ functions. Nutrients 2017;9(4):335–360.
   Web of Science ®Google Scholar
• Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008;585(1):97–108. doi: 10.1016/j.ejphar.2008.02.049
   PubMed Web of Science ®Google Scholar
• Zhagn L, Li Z. [Alzheimer and the discovery of Alzheimer’s disease]. Zhonghua Yi Shi Za Zhi 2014;44(5):288–90.
   PubMedGoogle Scholar
• Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 2016;18(5):421–30. doi: 10.1038/gim.2015.117
   PubMed Web of Science ®Google Scholar
• Li X, Song D, Leng SX. Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 2015;10:549–60. doi: 10.2147/CIA.S74042
   PubMed Web of Science ®Google Scholar
• Takeda S, Sato N, Rakugi H, Morishita R. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function. Mol Biosyst 2011;7(6):1822–7. doi: 10.1039/c0mb00302f
   PubMed Web of Science ®Google Scholar
• Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009;118(1):53–69. doi: 10.1007/s00401-009-0486-3
   PubMed Web of Science ®Google Scholar
• Takashima A. [Drug development for tauopathy and Alzheimer’s disease]. Nihon Shinkei Seishin Yakurigaku Zasshi 2010;30(4):177–80.
   PubMedGoogle Scholar
• O’Brien JT, Burns A. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2011;25(8):997–1019. doi: 10.1177/0269881110387547
   PubMed Web of Science ®Google Scholar
• Wen MM, El-Salamouni NS, El-Refaie WM, Hazzah HA, Ali MM, Tosi G, et al. Nanotechnology-based drug delivery systems for Alzheimer’s disease management: technical, industrial, and clinical challenges. J Control Release 2017;245:95–107. doi: 10.1016/j.jconrel.2016.11.025
   PubMed Web of Science ®Google Scholar
• Cheng H, Shang Y, Jiang L, Shi TL, Wang L. The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer’s disease and mild-to-moderate Alzheimer’s disease: a meta-analysis. Int J Neurosci 2016;126(4):299–307. doi: 10.3109/00207454.2015.1015722
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Sun W, Li J, Padmanabhan J. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity. PLoS One 2015;10(4):e0123864. doi: 10.1371/journal.pone.0123864
   PubMed Web of Science ®Google Scholar
• Papadopoulos P, Rosa-Neto P, Rochford J, Hamel E, Ginsberg SD. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer’s disease with combined amyloid-beta and cerebrovascular pathology. PLoS One 2013;8(7):e68612. doi: 10.1371/journal.pone.0068612
   PubMed Web of Science ®Google Scholar
• Feng Y, Wang X. Antioxidant therapies for Alzheimer’s disease. Oxid Med Cell Longev 2012;2012:1–17. doi: 10.1155/2012/472932
   Web of Science ®Google Scholar
• Anderson RA, Qin B, Canini F, Poulet L, Roussel AM, Bassaganya-Riera J. Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes. PLoS One 2013;8(12):e83243. doi: 10.1371/journal.pone.0083243
   PubMed Web of Science ®Google Scholar
• Yin Q, Ma Y, Hong Y, Hou X, Chen J, Shen C, et al. Lycopene attenuates insulin signaling deficits, oxidative stress, neuroinflammation, and cognitive impairment in fructose-drinking insulin resistant rats. Neuropharmacology 2014;86:389–96. doi: 10.1016/j.neuropharm.2014.07.020
   PubMed Web of Science ®Google Scholar
• Choi BK, Park SB, Lee DR, Lee HJ, Jin YY, Yang SH, et al. Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice. Asian Pac J Trop Med 2016;9(7):635–43. doi: 10.1016/j.apjtm.2016.05.017
   PubMed Web of Science ®Google Scholar
• Ho L, Varghese M, Wang J, Zhao W, Chen F, Knable LA, et al. Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutr Neurosci 2012;15(1):37–45. doi: 10.1179/1476830511Y.0000000027
   PubMed Web of Science ®Google Scholar
• Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, et al. Advances in the prevention of Alzheimer’s disease and dementia. J Intern Med 2014;275(3):229–50. doi: 10.1111/joim.12178
   PubMed Web of Science ®Google Scholar
• Luo D, Hou X, Hou L, Wang M, Xu S, Dong C, et al. Effect of pioglitazone on altered expression of Abeta metabolism-associated molecules in the brain of fructose-drinking rats, a rodent model of insulin resistance. Eur J Pharmacol 2011;664(1–3):14–9. doi: 10.1016/j.ejphar.2011.04.045
   PubMed Web of Science ®Google Scholar
• Pham N, Dhar A, Khalaj S, Desai K, Taghibiglou C. Down regulation of brain cellular prion protein in an animal model of insulin resistance: possible implication in increased prevalence of stroke in pre-diabetics/diabetics. Biochem Biophys Res Commun 2014;448(2):151–6. doi: 10.1016/j.bbrc.2014.04.071
   PubMed Web of Science ®Google Scholar
• Ghafouri S, Fathollahi Y, Javan M, Shojaei A, Asgari A, Mirnajafi-Zadeh J. Effect of low frequency stimulation on impaired spontaneous alternation behavior of kindled rats in Y-maze test. Epilepsy Res 2016;126:37–44. doi: 10.1016/j.eplepsyres.2016.06.010
   PubMed Web of Science ®Google Scholar
• Yin QQ, Pei JJ, Xu S, Luo DZ, Dong SQ, Sun MH, et al. Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats. PLoS One 2013;8(3):e59313. doi: 10.1371/journal.pone.0059313
   PubMed Web of Science ®Google Scholar
• Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000;106(2):165–9. doi: 10.1172/JCI10582
   PubMed Web of Science ®Google Scholar
• Diehl T, Mullins R. D. Insulin resistance in Alzheimer's disease. Transl Res. 2017;183:26–40. doi: 10.1016/j.trsl.2016.12.005
   PubMed Web of Science ®Google Scholar
• Popkie AP, Zeidner LC, Albrecht AM, D’Ippolito A, Eckardt S, Newsom DE, et al. Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J Biol Chem 2010;285(53):41337–47. doi: 10.1074/jbc.M110.170704
   PubMed Web of Science ®Google Scholar
• Gao C, Holscher C, Liu Y, Li L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci 2011;23(1):1–11. doi: 10.1515/rns.2011.061
   PubMed Web of Science ®Google Scholar
• Djordjevic A, Bursac B, Velickovic N, Vasiljevic A, Matic G. The impact of different fructose loads on insulin sensitivity, inflammation, and PSA-NCAM-mediated plasticity in the hippocampus of fructose-fed male rats. Nutr Neurosci 2015;18(2):66–75. doi: 10.1179/1476830513Y.0000000098
   PubMed Web of Science ®Google Scholar
• Yarchoan M, Toledo JB, Lee EB, Arvanitakis Z, Kazi H, Han LY, et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies. Acta Neuropathol 2014;128(5):679–89. doi: 10.1007/s00401-014-1328-5
   PubMed Web of Science ®Google Scholar
• Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122(4):1316–38. doi: 10.1172/JCI59903
   PubMed Web of Science ®Google Scholar
• Peng D, Pan X, Cui J, Ren Y, Zhang J. Hyperphosphorylation of tau protein in hippocampus of central insulin-resistant rats is associated with cognitive impairment. Cell Physiol Biochem 2013;32(5):1417–25. doi: 10.1159/000356579
   PubMed Web of Science ®Google Scholar
• Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, et al. Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U S A 2004;101(9):3100–5. doi: 10.1073/pnas.0308724101
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX. Deficient brain insulin signalling pathway in Alzheimer’s disease and diabetes. J Pathol 2011;225(1):54–62. doi: 10.1002/path.2912
   PubMed Web of Science ®Google Scholar
• de la Monte SM. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer’s disease. Drugs 2012;72(1):49–66. doi: 10.2165/11597760-000000000-00000
   PubMed Web of Science ®Google Scholar
• Wang J, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 2001;507(1):81–7. doi: 10.1016/S0014-5793(01)02944-1
   PubMed Web of Science ®Google Scholar
• Xu W, Liu J, Ma D, Yuan G, Lu Y, Yang Y. Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats. PLoS One 2017;12(2):e0172477. doi: 10.1371/journal.pone.0172477
   PubMed Web of Science ®Google Scholar
• Kang S, Kim CH, Jung H, Kim E, Song HT, Lee JE. Agmatine ameliorates type 2 diabetes induced-Alzheimer’s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Neuropharmacology 2017;113(Pt A):467–79. doi: 10.1016/j.neuropharm.2016.10.029
   PubMedGoogle Scholar
• Hoscheidt SM, Starks EJ, Oh JM, Zetterberg H, Blennow K, Krause RA, et al. Insulin resistance is associated with increased levels of cerebrospinal fluid biomarkers of Alzheimer’s disease and reduced memory function in At-risk healthy middle-aged adults. J Alzheimers Dis 2016;52(4):1373–83. doi: 10.3233/JAD-160110
   PubMed Web of Science ®Google Scholar
• Song SJ, Choi S, Park T. Decaffeinated green coffee bean extract attenuates diet-induced obesity and insulin resistance in mice. Evid Based Complement Alternat Med 2014;2014:718379.
   PubMed Web of Science ®Google Scholar
• Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med 2006;6:1–9.
   PubMedGoogle Scholar
• Vinson JA, Burnham BR, Nagendran MV. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes 2012;5:21–7. doi: 10.2147/DMSO.S27665
   PubMedGoogle Scholar
• Hamano T, Shirafuji N, Makino C, Yen SH, Kanaan NM, Ueno A, et al. Pioglitazone prevents tau oligomerization. Biochem Biophys Res Commun 2016;478(3):1035–42. doi: 10.1016/j.bbrc.2016.08.016
   PubMed Web of Science ®Google Scholar
• Fernandez-Martos CM, Atkinson RAK, Chuah MI, King AE, Vickers JC. Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer’s disease. Alzheimer’s & Dementia: Transl Res Clin Interv. 2017;3:92–106.
   PubMedGoogle Scholar